Espen Enerly, MSc PhD

Researcher, HPV-related Epidemiological Research Unit

 

E-mail: espen.enerly @kreftregisteret.no  Telephone: (+47) 22 92 88 00

Espen on LinkedIn

Espen on ResearchGate

Espen on Twitter

 

Bio:

Espen Enerly genetically modified plants and fruit flies in the laboratory at the University of Oslo, which resulted in the degrees Cand. Scient, and Dr. Scient. Here, the fascination for non-protein genes (RNA genes) was sparked, and an interest in its genomics was later developed and studied at the Institute of Bioinformatics (A*STAR, Singapore). Espen has later studied the RNA genes relation to breast cancer at the Radium Hospital in Norway.

Since 2010, Espen har worked as a researcher at the Cancer Registry of Norway, in the HPV-related Epidemiological Research Unit. He has primarily studied long-term follow up of subjects who received the HPV-vaccine. Lately, he has also worked on how to better facilitate research collaboration between the Cancer Registry and the pharmaceutical industry (e.g. lung cancer). 

   

Projects:

SVEIP - EFFECT OF SCHOOL BASED HPV-VACCINATION IN THE POPULATION

LTFU: LONG-TERM FOLLOW UP OF SUBJECTS PARTICIPATING IN THE CLINICAL TRIALS OF THE HPV-VACCINE

REGISTER BASED DESCRIPTIVE STUDY OF PROGRESSION AND REGRESSION OF WOMEN WITH PRECANCEROUS CERVICAL LESIONS (Norwegian only)


Publications:

PubMed

 

Media:

Workshop - Real World Data (01.11.2016, Norwegian only)

Hjemmetest av livmorhals (15.04.2016, Norwegian only)

Testikkelkreftvev mangler nyoppdaget genmateriale (13.09.2015, Norwegian only)


 

Regarding questions received by the Cancer Registry of Norway

The Cancer Registry of Norway is a research institute. Our staff will therefore not answer questions on diagnosis and treatment or on follow-up from individual patients or their families. These questions should be directed to your physician, hospital or the Cancer Helpline of the Norwegian Cancer Society, Telephone: 800-57 338 (800 KREFT)



Back to Researchers at the Cancer registry of Norway